Advertisement
U.S. markets open in 6 hours 47 minutes

GeoVax Labs, Inc. (GOVX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
1.8900+0.0300 (+1.61%)
At close: 04:00PM EDT
2.0000 +0.11 (+5.82%)
After hours: 07:18PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Relative Strength Index (RSI)

Relative Strength Index (RSI)

Previous Close1.8600
Open1.9400
Bid2.1400 x 900
Ask2.3500 x 1100
Day's Range1.8400 - 1.9400
52 Week Range1.8200 - 11.8500
Volume25,142
Avg. Volume39,743
Market Cap4.106M
Beta (5Y Monthly)2.92
PE Ratio (TTM)N/A
EPS (TTM)-14.2900
Earnings DateMay 02, 2024 - May 06, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est76.25
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for GOVX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • GeoVax Labs, Inc.
    Weekly Stock ListWe see what we believe are some great opportunities right now in Healthcare -- and we like the sector overall. Argus Director of Research Jim Kelleher, CFA, recently completed his quarterly sector review and raised Healthcare sector to Over-Weight from Market-Weight. The healthcare environment is undergoing rapid transitions, and we now see an unfolding period of significant promise and opportunity. Our newly-favored stance is based on resumption of deferred medical procedures and significant new quality-of-life drugs and treatments. The category is broad and has underperformed the S&P 500 over the past year. The Healthcare sector ETF (XLV) is up 15% over the past year compared to a gain of 31% for the S&P 500. We see opportunity here to pick up some steady companies, with big brands and solid financials. These companies are science-focused and enhance lives. They are innovators. In our list this week, we look across several subsectors within the Healthcare sector and pull out some leaders we like. These stocks also are included in our Focus List and Model Portfolios, as noted below.
    Rating
    Fair Value
    Economic Moat
    19 hours agoArgus Research
View more
  • NewMediaWire

    GeoVax to Present at the 36th Annual Roth Conference

    ATLANTA, GA - (NewMediaWire) - March 12, 2024 - GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, announced today that its Chairman and CEO, David Dodd, will pre...

  • GlobeNewswire

    GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System

    Manufacturing Process for Phase 3 and Commercial Production Being Developed for GeoVax MVA-Based Vaccines ATLANTA, GA, March 06, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced a significant milestone toward implementation of a validated chicken embryonic fibroblast (CEF) based production system for the company’s MVA-based vaccines, with the relea

  • Insider Monkey

    GeoVax Labs, Inc. (NASDAQ:GOVX) Q4 2023 Earnings Call Transcript

    GeoVax Labs, Inc. (NASDAQ:GOVX) Q4 2023 Earnings Call Transcript March 1, 2024 GeoVax Labs, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, and welcome, everyone, to the GeoVax Fourth Quarter 2023 Corporate Update Call. My name is […]